Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Alpha Synuclein Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 AV-1950R
  • 1.3.3 AV-1947D
  • 1.3.4 BAN-0805
  • 1.3.5 BIIB-054
  • 1.3.6 DPC-003
  • 1.3.7 Others
• 1.4 Market Segment by Application
  • 1.4.1 Global Alpha Synuclein Market Share by Application (2019-2025)
  • 1.4.2 Multiple System Atrophy
  • 1.4.3 Neurodegenerateive Disease
  • 1.4.4 Lewy Body Dementia
  • 1.4.5 Others
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Alpha Synuclein Market Size
  • 2.1.1 Global Alpha Synuclein Revenue 2014-2025
  • 2.1.2 Global Alpha Synuclein Sales 2014-2025
• 2.2 Alpha Synuclein Growth Rate by Regions
  • 2.2.1 Global Alpha Synuclein Sales by Regions 2014-2019
  • 2.2.2 Global Alpha Synuclein Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Alpha Synuclein Sales by Manufacturers
  • 3.1.1 Alpha Synuclein Sales by Manufacturers 2014-2019
  • 3.1.2 Alpha Synuclein Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Alpha Synuclein Revenue by Manufacturers (2014-2019)
  • 3.2.2 Alpha Synuclein Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Alpha Synuclein Market Concentration Ratio (CR5 and HHI)
• 3.3 Alpha Synuclein Price by Manufacturers
• 3.4 Key Manufacturers Alpha Synuclein Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Alpha Synuclein Market
• 3.6 Key Manufacturers Alpha Synuclein Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 AV-1950R Sales and Revenue (2014-2019)
  • 4.1.2 AV-1947D Sales and Revenue (2014-2019)
  • 4.1.3 BAN-0805 Sales and Revenue (2014-2019)
  • 4.1.4 BIIB-054 Sales and Revenue (2014-2019)
  • 4.1.5 DPC-003 Sales and Revenue (2014-2019)
  • 4.1.6 Others Sales and Revenue (2014-2019)
• 4.2 Global Alpha Synuclein Sales Market Share by Type
• 4.3 Global Alpha Synuclein Revenue Market Share by Type
• 4.4 Alpha Synuclein Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Alpha Synuclein Sales by Application

6 United States

• 6.1 United States Alpha Synuclein Breakdown Data by Company
• 6.2 United States Alpha Synuclein Breakdown Data by Type
• 6.3 United States Alpha Synuclein Breakdown Data by Application

7 European Union

• 7.1 European Union Alpha Synuclein Breakdown Data by Company
• 7.2 European Union Alpha Synuclein Breakdown Data by Type
• 7.3 European Union Alpha Synuclein Breakdown Data by Application

8 China

• 8.1 China Alpha Synuclein Breakdown Data by Company
• 8.2 China Alpha Synuclein Breakdown Data by Type
• 8.3 China Alpha Synuclein Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Alpha Synuclein Breakdown Data by Company
• 9.2 Rest of World Alpha Synuclein Breakdown Data by Type
• 9.3 Rest of World Alpha Synuclein Breakdown Data by Application
• 9.4 Rest of World Alpha Synuclein Breakdown Data by Countries
  • 9.4.1 Rest of World Alpha Synuclein Sales by Countries
  • 9.4.2 Rest of World Alpha Synuclein Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 AC Immune SA
  • 10.1.1 AC Immune SA Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Alpha Synuclein
  • 10.1.4 Alpha Synuclein Product Introduction
  • 10.1.5 AC Immune SA Recent Development
• 10.2 AFFiRiS AG
  • 10.2.1 AFFiRiS AG Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Alpha Synuclein
  • 10.2.4 Alpha Synuclein Product Introduction
  • 10.2.5 AFFiRiS AG Recent Development
• 10.3 BioArctic AB
  • 10.3.1 BioArctic AB Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Alpha Synuclein
  • 10.3.4 Alpha Synuclein Product Introduction
  • 10.3.5 BioArctic AB Recent Development
• 10.4 Biogen Inc
  • 10.4.1 Biogen Inc Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Alpha Synuclein
  • 10.4.4 Alpha Synuclein Product Introduction
  • 10.4.5 Biogen Inc Recent Development
• 10.5 Evotec AG
  • 10.5.1 Evotec AG Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Alpha Synuclein
  • 10.5.4 Alpha Synuclein Product Introduction
  • 10.5.5 Evotec AG Recent Development
• 10.6 Genmab A/S
  • 10.6.1 Genmab A/S Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Alpha Synuclein
  • 10.6.4 Alpha Synuclein Product Introduction
  • 10.6.5 Genmab A/S Recent Development
• 10.7 H. Lundbeck A/S
  • 10.7.1 H. Lundbeck A/S Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of Alpha Synuclein
  • 10.7.4 Alpha Synuclein Product Introduction
  • 10.7.5 H. Lundbeck A/S Recent Development
• 10.8 ICB International Inc
  • 10.8.1 ICB International Inc Company Details
  • 10.8.2 Company Description and Business Overview
  • 10.8.3 Sales, Revenue and Market Share of Alpha Synuclein
  • 10.8.4 Alpha Synuclein Product Introduction
  • 10.8.5 ICB International Inc Recent Development
• 10.9 MedImmune LLC
  • 10.9.1 MedImmune LLC Company Details
  • 10.9.2 Company Description and Business Overview
  • 10.9.3 Sales, Revenue and Market Share of Alpha Synuclein
  • 10.9.4 Alpha Synuclein Product Introduction
  • 10.9.5 MedImmune LLC Recent Development
• 10.10 Neuropore Therapies Inc
  • 10.10.1 Neuropore Therapies Inc Company Details
  • 10.10.2 Company Description and Business Overview
  • 10.10.3 Sales, Revenue and Market Share of Alpha Synuclein
  • 10.10.4 Alpha Synuclein Product Introduction
  • 10.10.5 Neuropore Therapies Inc Recent Development
• 10.11 nLife Therapeutics SL
• 10.12 Prothena Corp Plc
• 10.13 QR Pharma Inc
• 10.14 reMYND NV

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Alpha Synuclein Sales Channels
  • 11.2.2 Alpha Synuclein Distributors
• 11.3 Alpha Synuclein Customers

12 Market Forecast

• 12.1 Global Alpha Synuclein Sales and Revenue Forecast 2019-2025
• 12.2 Global Alpha Synuclein Sales Forecast by Type
• 12.3 Global Alpha Synuclein Sales Forecast by Application
• 12.4 Alpha Synuclein Forecast by Regions
  • 12.4.1 Global Alpha Synuclein Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Alpha Synuclein Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

In 2019, the market size of Alpha Synuclein is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Alpha Synuclein.

This report studies the global market size of Alpha Synuclein, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Alpha Synuclein sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
AC Immune SA
AFFiRiS AG
BioArctic AB
Biogen Inc
Evotec AG
Genmab A/S
H. Lundbeck A/S
ICB International Inc
MedImmune LLC
Neuropore Therapies Inc
nLife Therapeutics SL
Prothena Corp Plc
QR Pharma Inc
reMYND NV

Market Segment by Product Type
AV-1950R
AV-1947D
BAN-0805
BIIB-054
DPC-003
Others

Market Segment by Application
Multiple System Atrophy
Neurodegenerateive Disease
Lewy Body Dementia
Others

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Alpha Synuclein status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Alpha Synuclein manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Alpha Synuclein are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025